山东医药2020年第60卷第30期
[6]Le Hello S,Falcot V,Lacassin F,et al.Molecular epidemiology
of carbapenem-resistant Acinetobacter baumannii in New Caledonia [J].Clin Microbiol Infect,2008,14(10)：977-981.
[7]Park YK,Lee GH,Baek JY,et al.A single clone of Acinetobact­seifert
er baumannii,ST22,is responsible for high antimicrobial resist­ance rates of Acinetobacter spp.isolates that cause bacteremia and urinary tract infections in Korea[J].Microb Drug Resist，2010，16
(2):143-149.
[8]Roach S，Wallinga D.Commentary on genetic mechanisms of anti­
microbial resistance in bacteria from U.S.food animals:ESBLs are here[J].Front Microbiol，2013，4:214.
[9]Saeed Shoja,Mojtaba Moosavian,Soodabeh Rostami,et al.Char­
acterization of oxacillinase and metallo-0-lactamas genes and mo­lecular typing of clinical isolates of acinetobacter baumannii in ah-vaz,south-west of iran[J].Jundishapur J Microbiol,2016,9(5): 32388.
[10]Bartual SG,Seifert H,Hippler C,et al.Development of a multilo­
cus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii]J].J Clin Microbiol,2005,43(9): 4382-4390.
[11]Jones RN,Ferraro MJ,Reller LB,et al.Multicenter studies of
tigecycline disk diffusion susceptibility results for Acinetobacter spp [J].J Clin Microbiol,2007,45(1)：227-230.
[12]Cicek AC,Saral A,Iraz M,et al.OXA-and GES-type beta-lacta­
mases predominate in extensively drug-resistant Acinetobacter bau-mannii isolates from a Turkish University Hospital[J] .Clin Micro­biol Infect,2014,20(5)：410415.
[13]Chung DR,Song JH,Kim SH,et al.High prevalence of multi­
drug-resistant nonfermenters in hospital-acquired pneumonia in A-sia[J].Am J Respir Crit Care Med,2011,184(12)：1409-1417.
[14]Chittawatanarat K,Jaipakdee W,Chotirosniramit N,et al.Micro-
biology，resistance patterns，and risk factors of mortality in ventila­
tor-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit[J].Infect Drug Resist，2014，7:203-210.
[15]Inchai J，Pothirat C，Liwsrisakun C，et al.Ventilator-associated
pneumonia:epidemiology and prognostic indicators of30-day mor-tality[J].Jpn J Infect Dis,2015,68(3)：181-186.
[16]Park S，Kim HS，Lee KM，et al.Molecular and epidemiological
characterization of carbapenem-resistant Acinetobacter baumannii in non-tertiary Korean hospitals[J].Yonsei Med J,2013,54(1): 177-182.
[17]Huang L,Sun L,Yan Y.Clonal spread of carbapenem resistant
Acinetobacter baumannii ST492in a Chinese Hospital during a6­year period[J].J Microbiol,2013,51(1)：113-117.
[18]Peleg AY，Seifert H，Paterson DL.Acinetobacter baumannii:e­
mergence of a successful pathogen[J].Clin Microbiol Rev,2008, 21(3):538-582.
[19]Martins N,Martins IS,de Freitas WV,et al.Imported and inten­
sive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients[J].
Microb Drug Resist,2013,19(3)：216-223.
[20]Stietz MS，Ramirez MS，Vilacoba E，et al.Acinetobacter bauman-
nii extensively drug resistant lineages in Buenos Aires hospitals dif­fer from the international clones[J].Infect Genet Evol,2013,14：294-301.
[21]Merli M,Lucidi C,Giannelli V,et al.Cirrhotic patients are at
risk for health care-associated bacterial infections[J] .Clin Gastro­enterol Hepatol,2010,(11)：979-985.
[22]Kempf M,Rolain JM.Emergence of resistance to carbapenems in
Acinetobacter baumannii in Europe:clinical impact and therapeu­tic options[J].Int J Antimicrob Agents,2012,39(2):105-114.
(收稿日期：2020-06-21)
-作者•编者•读者•
《山东医药》关于医学名词与统计学符号的使用说明
医学名词要以1989年及以后由全国自然科学名词审定委员会审定、公布，科学出版社出版的《医学名词》和相关科学的名词为准，暂未公布者仍以人民卫生出版社出版的《英汉医学词汇》为准。中文药物名称应使用1995年药典（法定药物）或卫生部药典委员会编辑的《药名词汇》（非法定药物）中的名称，英文药物名称则采用国际非专利药名，不用商品名。
按GB3358-82《统计学名词及符号》的有关规定书写，常用统计学符号的书写如下：①样本的算术平
均数用英文小写珋中位数仍用M）；②标准差用英文小写s；③t检验用英文小写t；④F检验用英文大写F;⑤卡方检验用希文小写x2:⑥相关系数用英文小写r；⑦自由度用希文小写v；⑧概率用英文大写P。以上符号均用斜体。
17

版权声明：本站内容均来自互联网，仅供演示用，请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系QQ:729038198，我们将在24小时内删除。